Logo image of KLY.CA

Kalytera Therapeutics Inc (KLY.CA) Stock Price, Forecast & Analysis

Canada - TSX Venture Exchange - TSX-V:KLY -

0.045
0 (0%)
Last: 4/9/2021, 3:54:46 PM

KLY.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap25.70M
Revenue(TTM)N/A
Net Income(TTM)-15.41M
Shares571.03M
FloatN/A
52 Week High0.11
52 Week Low0.01
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.03
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
KLY.CA short term performance overview.The bars show the price performance of KLY.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150

KLY.CA long term performance overview.The bars show the price performance of KLY.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 2 4 6 8 10

The current stock price of KLY.CA is 0.045 null. In the past year, price increased by 12.5%.

Kalytera Therapeutics Inc / KLY Daily stock chart

KLY.CA Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to KLY.CA. When comparing the yearly performance of all stocks, KLY.CA is one of the better performing stocks in the market, outperforming 80.63% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

KLY.CA Financial Highlights

Over the last trailing twelve months KLY.CA reported a non-GAAP Earnings per Share(EPS) of -0.033.


Industry RankSector Rank
PM (TTM) N/A
ROA -141.6%
ROE N/A
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%N/A
EPS 1Y (TTM)0%
Revenue 1Y (TTM)N/A

KLY.CA Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y100%
Revenue Next YearN/A

KLY.CA Ownership

Ownership
Inst Owners0.02%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About KLY.CA

Company Profile

Company Info

Kalytera Therapeutics Inc

4040 Civic Center Drive

San Rafael CA 94903

CEO: Robert E. Farrell

Phone: +1 415 218-3900

Kalytera Therapeutics Inc / KLY.CA FAQ

Can you provide the latest stock price for Kalytera Therapeutics Inc?

The current stock price of KLY.CA is 0.045 null.


Does KLY stock pay dividends?

KLY.CA does not pay a dividend.


How is the ChartMill rating for Kalytera Therapeutics Inc?

KLY.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Can you provide the market cap for Kalytera Therapeutics Inc?

Kalytera Therapeutics Inc (KLY.CA) has a market capitalization of 25.70M null. This makes KLY.CA a Nano Cap stock.


Can you provide the ownership details for KLY stock?

You can find the ownership structure of Kalytera Therapeutics Inc (KLY.CA) on the Ownership tab.